← Back
Data updated: Mar 10, 2026
CR DOUBLE CRANE
Pharmaceuticals
CR DOUBLE CRANE is a generic drug manufacturer with 2 FDA-approved products.
2002
Since
2
Drugs
-
Trials
52
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-08-13
Labeling
FLUOXETINE HYDROCHLORIDE 2025-07-11
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-05-05
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-02-04
Labeling
MELOXICAM 2024-12-23
Manufacturing (CMC)
MELOXICAM 2024-12-16
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2002-02-01
- Latest
- 2024-11-26
- Applications
- 2